Hainan Haina Pharma: Subsidiary's injection of meropenem passes generic drug consistency evaluation.

Hainan Haiyao announced that its wholly-owned subsidiary, Haikou Pharmaceutical Factory Co., Ltd., recently obtained the "Drug Supplementary Application Approval Notice" for the chemical drug meropenem injection issued by the National Medical Products Administration. According to relevant national policies, generic drugs that have undergone consistency evaluation have the same quality and efficacy as the original research products. This consistency evaluation of the meropenem injection will help enhance the market competitiveness of the drug and have a positive impact on the company's performance.